DCM Advisors LLC Sells 10,920 Shares of CVS Health Corporation $CVS

Key Points

• DCM Advisors LLC has reduced its position in CVS Health by 13.4%, now holding 70,610 shares valued at approximately $4.76 million.
• CVS Health reported strong earnings for the last quarter, with earnings per share of $1.81, surpassing estimates by $0.35, and revenue of $98.92 billion, beating expectations by $4.05 billion.
• Analysts are generally bullish on CVS Health, with 19 "Buy" ratings and an average price target of $77.89, reflecting growing confidence in the company's performance.

DCM Advisors LLC lessened its stake in CVS Health Corporation (NYSE:CVS - Free Report) by 13.4% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 70,610 shares of the pharmacy operator's stock after selling 10,920 shares during the quarter. CVS Health comprises approximately 2.5% of DCM Advisors LLC's investment portfolio, making the stock its 19th biggest holding. DCM Advisors LLC's holdings in CVS Health were worth $4,761,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the business. Vanguard Group Inc. grew its position in shares of CVS Health by 0.8% during the 1st quarter. Vanguard Group Inc. now owns 118,335,394 shares of the pharmacy operator's stock worth $8,017,223,000 after buying an additional 969,027 shares during the period. Dodge & Cox grew its position in shares of CVS Health by 4.8% during the 1st quarter. Dodge & Cox now owns 73,459,122 shares of the pharmacy operator's stock worth $4,976,856,000 after buying an additional 3,353,223 shares during the period. Invesco Ltd. boosted its position in shares of CVS Health by 13.2% in the 1st quarter. Invesco Ltd. now owns 20,413,853 shares of the pharmacy operator's stock worth $1,383,039,000 after purchasing an additional 2,375,764 shares during the last quarter. Price T Rowe Associates Inc. MD grew its stake in shares of CVS Health by 14.5% during the first quarter. Price T Rowe Associates Inc. MD now owns 15,309,289 shares of the pharmacy operator's stock worth $1,037,205,000 after purchasing an additional 1,942,886 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its holdings in CVS Health by 5.6% during the first quarter. Charles Schwab Investment Management Inc. now owns 13,647,873 shares of the pharmacy operator's stock worth $924,643,000 after buying an additional 728,924 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the stock. Cowen restated a "buy" rating on shares of CVS Health in a report on Monday, August 4th. Zacks Research lowered shares of CVS Health from a "strong-buy" rating to a "hold" rating in a research note on Monday. Sanford C. Bernstein lifted their price target on shares of CVS Health from $72.00 to $77.00 and gave the company a "market perform" rating in a research note on Friday, September 5th. UBS Group raised shares of CVS Health from a "neutral" rating to a "buy" rating and lifted their price target for the company from $67.00 to $79.00 in a research note on Monday, August 18th. Finally, Baird R W upgraded shares of CVS Health from a "hold" rating to a "strong-buy" rating in a report on Thursday, August 14th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $77.89.

Insider Buying and Selling

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of CVS Health stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the transaction, the director directly owned 22,156 shares of the company's stock, valued at $1,573,519.12. The trade was a 25.29% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.22% of the stock is currently owned by company insiders.

CVS Health Stock Performance

CVS stock traded up $0.33 during midday trading on Friday, reaching $75.00. 6,400,711 shares of the company were exchanged, compared to its average volume of 9,635,794. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62. The business has a 50-day moving average price of $66.96 and a two-hundred day moving average price of $66.22. CVS Health Corporation has a one year low of $43.56 and a one year high of $75.55. The firm has a market capitalization of $95.12 billion, a price-to-earnings ratio of 20.95, a price-to-earnings-growth ratio of 0.82 and a beta of 0.62.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 EPS for the quarter, topping analysts' consensus estimates of $1.46 by $0.35. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The firm had revenue of $98.92 billion during the quarter, compared to analysts' expectations of $94.87 billion. During the same period in the previous year, the business posted $1.83 earnings per share. The company's revenue for the quarter was up 8.4% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Equities research analysts forecast that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 1st. Shareholders of record on Tuesday, July 22nd were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.5%. The ex-dividend date of this dividend was Tuesday, July 22nd. CVS Health's payout ratio is 74.30%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.